Skip to main content
CERT logo

CERT · Certara, Inc.

Track CERT — free
$8.35 -0.06 (-0.71%) At close · Aug 28
Market Cap
$1.27B
Shares
152.54M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$418.84M +8.7%
FY2025 Revenue FY2019–FY2025
Net Income
-$1.6M +86.8%
FY2025 Net Income FY2019–FY2025
Gross Margin
60.2% -0.3pp
FY2023 Gross Margin FY2019–FY2023
Operating Margin
5.02% +5.5pp
FY2025 Operating Margin FY2019–FY2025
Diluted EPS
-$0.01 +87.5%
FY2025 Diluted EPS FY2019–FY2025
Operating Cash Flow
$96.33M +19.7%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item FY2026 (G) TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
$367M – $382M $420.66M $418.84MG $385.15MG $354.34MG $335.64MG $286.1M $243.53M $208.51M
$141.02M $132.58M $111.62M $100.77M $79.77M
$213.32M $203.07M $174.49M $142.77M $128.74M
60.2% 60.5% 60.99% 58.62% 61.74%
$43.54M $41.04M $37.11M $34.17M $28.21M $20.38M $19.64M $11.63M
$55.68M $53.72M $47.44M $32.02M $27.41M $20.14M $19.2M $10.73M
$100.34M $85.38M $94.22M $95.39M $71.77M $79.54M $88.48M $47.93M
$73M $66.04M $54.52M $50.74M $42.98M $40.31M $38.96M
$76.3M $75.16M $68.03M $56.07M $1.73M $2.14M $2.44M $2.6M
$257.38M $236.7M $232.36M $254.09M $170.55M $160.91M $167.19M $109.13M
$1.22M $21.02M -$1.73M -$40.77M $32.52M $13.58M -$24.42M $19.61M
5.02% -0.45% -11.51% 9.69% 4.75% -10.03% 9.41%
$77.52M $96.18M $66.3M $15.3M $34.25M $15.71M -$21.98M $22.21M
$20.06M $19.74M $21.52M $22.92M $17.77M $16.84M $25.3M $28M
-$16.85M -$13.4M -$15.45M -$14.37M -$13.77M -$16.95M -$25.76M -$28.76M
-$15.63M $7.62M -$17.18M -$55.14M $18.76M -$3.38M -$50.18M -$9.15M
$7.05M $9.21M -$5.13M $214K $4.02M $9.89M -$784K -$225K
-$68.4M -$1.6M -$12.05M -$55.36M $14.73M -$13.27M -$49.4M -$8.93M
-0.38% -3.13% -15.62% 4.39% -4.64% -20.28% -4.28%
-$64.3M $13.87M -$17.88M -$54.72M $10.43M -$15.61M -$45.49M -$12.78M
USD/shares -$0.45 -$0.01 -$0.08 -$0.35 $0.09 -$0.09 -$0.37 -$0.07
USD/shares $0.31 – $0.36* -$0.45 -$0.01G -$0.08G -$0.35G $0.09G -$0.09 -$0.37 -$0.07
shares 160.39M 160.39M 158.94M 156.88M 149.84M 133.25M 132.41M
shares 160.39M 160.39M 158.94M 159.35M 149.84M 133.25M 132.41M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2019–FY2025: $44.39M in buybacks.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
3.28×
Peer median 3.80×
EV/EBIT
1,129.52×
Peer median 27.20×
P/E (TTM)
Peer median 38.63×
EV/Adj. EBITDA (FY2026)
26.12×
Peer median 10.66×

Peer medians compare against the 26 similar-size Health Information Services companies (of 45 listed).

EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings — the company's own non-GAAP definition, not an XBRL-tagged figure.

Valuation over time computed as of each quarter's filing date

EV/Adj. EBITDA uses the company-stated “Adjusted EBITDA”, extracted from the reconciliation in its SEC filings as it existed at each sample date — the company's own non-GAAP definition, not an XBRL-tagged figure. Each point's tooltip names its TTM or fiscal-year basis.

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component FY2025 FY2024 FY2023 FY2022
Reportable Segment $418,838,000 $385,148,000 $354,337,000
Bio Simulation Technology Segment $335,644,000

By Geography (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Americas $291,601,000 $281,493,000 $265,063,000 $252,921,000 $205,377,000 $182,629,000 $154,505,000
EMEA $92,629,000 $76,567,000 $63,567,000 $57,002,000 $56,410,000 $42,844,000 $40,299,000
Asia Pacific $34,608,000 $27,088,000 $25,707,000 $25,721,000 $24,317,000 $18,057,000 $13,707,000
Key facts CIK 1827090 CUSIP 15687V109 13F (30d) 214 filings 195 filers Visit website Investor relations